- /
- Supported exchanges
- / US
- / TECX.NASDAQ
Tectonic Therapeutic, Inc. (TECX NASDAQ) stock market data APIs
Tectonic Therapeutic, Inc. Financial Data Overview
Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPCR modulator bispecific for treating fibrosis; and other GPCR modulators. The company is headquartered in Watertown, Massachusetts.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Tectonic Therapeutic, Inc. (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Tectonic Therapeutic, Inc. data using free add-ons & libraries
Get Tectonic Therapeutic, Inc. Fundamental Data
Tectonic Therapeutic, Inc. Fundamental data includes:
- Net Revenue:
- EBITDA: -93 661 000
- Earnings Per Share: -4
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get Tectonic Therapeutic, Inc. Earnings data
Corporate Events Calendar & News package for
What’s included:
- Latest Release: 2026-11-05
- EPS/Forecast: -1.38
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Tectonic Therapeutic, Inc. News
New
Tectonic Therapeutic (TECX) Clears Two Trial Hurdles With Cash To Spare
On August 6, Tectonic Therapeutic (NASDAQ:TECX) reported second quarter results built around two clinical wins rather than sales figures, since this is a clinical stage biotech company with no product...
5 Biotech Stocks That Delivered 100% To 300% Gains: Did Your Winning Trades Offset Portfolio Losses?
(RTTNews) - Even with strong research and disciplined stock selection, an investor may not get every stock pick right. As legendary investor Peter Lynch once said, "In this business, if you're good, y...
Top Biotech Gainers: PPCB Launches Share Buyback, VRXA Partners With ATUM, SLS On Watch
(RTTNews) - Today's top gainers include SL Science, which was recently listed on the Nasdaq; Chemomab, gearing up for a Phase 3 trial in primary sclerosing cholangitis; Propanc, following the launch o...
TD Asset Management Inc. Announces TD ETF Distributions
TORONTO, June 17, 2026 /CNW/ - TD Asset Management Inc. ("TDAM") today announced the June cash distributions for the TD Exchange-Traded Funds (each, a "TD ETF" and collectively, the "TD ETFs") and TD ...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.